TapImmune Inc Stock Nasdaq
Equities
US8760334081
Biotechnology & Medical Research
Sales 2022 | 9.01M 12.31M | Sales 2023 | 3.31M 4.52M | Capitalization | 48.89M 66.74M |
---|---|---|---|---|---|
Net income 2022 | -29M -39.59M | Net income 2023 | -8M -10.92M | EV / Sales 2022 | 2.06 x |
Net cash position 2022 | 4.17M 5.69M | Net cash position 2023 | 15.11M 20.63M | EV / Sales 2023 | 10.2 x |
P/E ratio 2022 |
-0.74
x | P/E ratio 2023 |
-5.88
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.83% |
Latest transcript on TapImmune Inc
Managers | Title | Age | Since |
---|---|---|---|
Juan F. Vera
CEO | Chief Executive Officer | 44 | 18-10-16 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 19-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 63 | 18-10-16 | |
Steven Elms
BRD | Director/Board Member | 60 | 19-08-05 |
Katharine Knobil
BRD | Director/Board Member | 60 | 21-12-07 |
1st Jan change | Capi. | |
---|---|---|
+2.47% | 42.75B | |
+47.70% | 41.61B | |
+11.94% | 41.34B | |
-8.83% | 26.59B | |
+7.33% | 25.49B | |
-22.70% | 18.12B | |
+30.49% | 12.24B | |
-2.06% | 11.76B | |
+9.22% | 11B |